|
WO2002018435A1
(fr)
*
|
2000-08-28 |
2002-03-07 |
Human Genome Sciences, Inc. |
18 protéines humaines sécrétées
|
|
US20020137890A1
(en)
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US6706262B1
(en)
|
1998-03-18 |
2004-03-16 |
Corixa Corporation |
Compounds and methods for therapy and diagnosis of lung cancer
|
|
US6960570B2
(en)
|
1998-03-18 |
2005-11-01 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
|
US7579160B2
(en)
|
1998-03-18 |
2009-08-25 |
Corixa Corporation |
Methods for the detection of cervical cancer
|
|
US7258860B2
(en)
|
1998-03-18 |
2007-08-21 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
|
JP3577586B2
(ja)
|
1998-05-15 |
2004-10-13 |
ジェネンテック・インコーポレーテッド |
Ｉｌ−１７相同的ポリペプチドとその治療用途
|
|
US7771719B1
(en)
|
2000-01-11 |
2010-08-10 |
Genentech, Inc. |
Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
|
|
US6929938B2
(en)
|
2001-08-15 |
2005-08-16 |
Millennium Pharmaceuticals, Inc. |
25501, a human transferase family member and uses therefor
|
|
US7141417B1
(en)
|
1999-02-25 |
2006-11-28 |
Thomas Jefferson University |
Compositions, kits, and methods relating to the human FEZ1 gene, a novel tumor suppressor gene
|
|
EP1163252A4
(fr)
*
|
1999-02-25 |
2004-04-07 |
Univ Jefferson |
Compositions, kits et procedes concernant le gene fez1 de l'homme, nouveau gene suppresseur des tumeurs
|
|
WO2000050458A1
(fr)
*
|
1999-02-26 |
2000-08-31 |
Smithkline Beecham Corporation |
Clonage du recepteur 7tm (axor 17) du type p2y
|
|
WO2000056881A1
(fr)
*
|
1999-03-23 |
2000-09-28 |
Human Genome Sciences, Inc. |
48 proteines humaines secretees
|
|
WO2000058480A1
(fr)
|
1999-03-29 |
2000-10-05 |
Kansai Technology Licensing Organization Co., Ltd. |
Nouvelle cytidine desaminase
|
|
EP1623992A3
(fr)
*
|
1999-09-01 |
2006-05-10 |
Genentech, Inc. |
Polypeptides sécrétés et transmembranaires ainsi que les acides nucléiques codant pour ceux-ci
|
|
US20020151047A1
(en)
*
|
2001-01-08 |
2002-10-17 |
Yi Hu |
Novel human protease and polynucleotides encoding the same
|
|
US6617147B2
(en)
|
2000-04-25 |
2003-09-09 |
Lexicon Genetics Incorporated |
Human kinase proteins and polynucleotides encoding the same
|
|
AU1238201A
(en)
*
|
1999-10-27 |
2001-05-08 |
Millennium Pharmaceuticals, Inc. |
Novel molecules and the card-related protein family and uses thereof
|
|
US6893818B1
(en)
|
1999-10-28 |
2005-05-17 |
Agensys, Inc. |
Gene upregulated in cancers of the prostate
|
|
US7005499B1
(en)
*
|
1999-11-18 |
2006-02-28 |
Genentech, Inc. |
Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same
|
|
EP1878794A3
(fr)
*
|
1999-11-30 |
2008-01-23 |
Genentech, Inc. |
Compositions et procédés pour le traitement de maladies liées au système immunitaire
|
|
CA2391455A1
(fr)
*
|
1999-12-01 |
2001-06-07 |
Genentech, Inc. |
Polypeptides secretes et transmembranaires et acides nucleiques codant ces polypeptides
|
|
CN1300781A
(zh)
*
|
1999-12-22 |
2001-06-27 |
上海博德基因开发有限公司 |
一种新的多肽-人shc蛋白43和编码这种多肽的多核苷酸
|
|
US20040043397A1
(en)
|
2000-01-11 |
2004-03-04 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
|
ES2360155T3
(es)
|
2000-01-26 |
2011-06-01 |
Agensys, Inc. |
84p2a9: una proteína específica de próstata y testículos altamente expresada en el cáncer de próstata.
|
|
US6953682B2
(en)
|
2000-02-10 |
2005-10-11 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid sequences encoding adenylate kinase, phospholipid scramblase-like, DNA fragmentation factor-like, phosphatidylserine synthase-like, and atpase-like molecules and uses therefor
|
|
US20020082212A1
(en)
*
|
2000-07-20 |
2002-06-27 |
Millennium Pharmaceuticals, Inc. |
7716, a novel human ATPase and uses therefor
|
|
US7078205B2
(en)
|
2000-02-17 |
2006-07-18 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecules, atpase molecules, acyltransferase molecules, pyridoxal-phosphate dependent enzyme molecules and uses therefor
|
|
US20020090705A1
(en)
*
|
2000-07-14 |
2002-07-11 |
Rachel Meyers |
62088, a novel human nucleoside phosphatase family member and uses thereof
|
|
US20020055159A1
(en)
*
|
2000-06-15 |
2002-05-09 |
Meyers Rachel A. |
23680,a novel human aminotransferase and uses therefor
|
|
US7718397B2
(en)
|
2000-03-21 |
2010-05-18 |
Genentech, Inc. |
Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
|
|
EP1268791A2
(fr)
*
|
2000-03-23 |
2003-01-02 |
Immusol Incorporated |
Regulateurs de brca-1 et procedes d'utilisation
|
|
EP1272640A2
(fr)
|
2000-03-24 |
2003-01-08 |
Millennium Pharmaceuticals, Inc. |
3714, 16742, 23546, et 13887 nouvelles molecules de proteine kinase et leurs utilisations
|
|
US20030198953A1
(en)
*
|
2000-03-30 |
2003-10-23 |
Spytek Kimberly A. |
Novel proteins and nucleic acids encoding same
|
|
US7632929B2
(en)
|
2000-04-20 |
2009-12-15 |
The Board Of Trustees Of The University Of Arkansas |
Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
|
|
AU2001257407A1
(en)
*
|
2000-04-26 |
2001-11-07 |
Millennium Pharmaceuticals, Inc. |
21657, a human short-chain dehydrogenase and uses thereof
|
|
US6808876B1
(en)
|
2000-05-02 |
2004-10-26 |
Immusol, Inc. |
Cellular regulators of infectious agents and methods of use
|
|
WO2001085921A2
(fr)
*
|
2000-05-12 |
2001-11-15 |
Merck Patent Gmbh |
Nouvelle serine-threonine kinase-4
|
|
US20040175815A1
(en)
*
|
2000-05-26 |
2004-09-09 |
Yonghong Xiao |
Regulation of human p78-like serube/threonine kinase
|
|
EP1158001B1
(fr)
*
|
2000-05-26 |
2007-11-14 |
F. Hoffmann-La Roche Ag |
Un acide nucléique produit excessivement dans des cellules tumorales humaines, une protéine codée par ledit acide nucléique et un procédé de diagnose de tumeurs
|
|
DE10027170A1
(de)
*
|
2000-05-31 |
2001-12-13 |
Schering Ag |
Humanes PEM als Target für die Fertilitätskontrolle
|
|
AU6531101A
(en)
*
|
2000-06-02 |
2001-12-17 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US7098311B2
(en)
*
|
2000-06-02 |
2006-08-29 |
Brigham And Women's Hospital |
Fusion of jAZF1 and jjAZ1 genes in endometrial stromal tumors
|
|
US20030096969A1
(en)
|
2000-06-02 |
2003-05-22 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
WO2001094385A2
(fr)
*
|
2000-06-05 |
2001-12-13 |
Bayer Aktiengesellschaft |
Regulation du recepteur couple a la proteine humaine g de type hm74
|
|
US6323016B1
(en)
|
2000-06-09 |
2001-11-27 |
Pe Corporation (Ny) |
Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
|
|
US20020040127A1
(en)
*
|
2000-06-09 |
2002-04-04 |
Yuqiu Jiang |
Compositions and methods for the therapy and diagnosis of colon cancer
|
|
CA2409315A1
(fr)
*
|
2000-06-16 |
2001-12-20 |
Incyte Genomics, Inc. |
Proteine-phosphatases
|
|
CA2709771A1
(fr)
*
|
2000-06-23 |
2002-01-03 |
Genentech, Inc. |
Compositions et methode de diagnostic et de traitement des troubles mettant en cause l'angiogenese
|
|
WO2002000861A2
(fr)
*
|
2000-06-26 |
2002-01-03 |
Millennium Pharmaceuticals, Inc. |
46619, une nouvelle synthase beta-cetoacyle et utilisations de cette derniere
|
|
US7094587B2
(en)
|
2000-06-27 |
2006-08-22 |
Millennium Pharmaceuticals, Inc. |
16002 Molecules and uses therefor
|
|
JP2004501623A
(ja)
*
|
2000-06-27 |
2004-01-22 |
キュラジェン コーポレイション |
ポリヌクレオチドおよびそれによってコードされるポリペプチド
|
|
US6774223B2
(en)
|
2000-06-28 |
2004-08-10 |
Diadexus, Inc. |
Method of diagnosing, monitoring, staging, imaging and treating colon cancer
|
|
US6900303B2
(en)
|
2000-06-30 |
2005-05-31 |
Millennium Pharmaceuticals, Inc. |
57658, a novel human uridine kinase and uses thereof
|
|
WO2002004510A2
(fr)
*
|
2000-07-07 |
2002-01-17 |
Incyte Genomics, Inc. |
Proteines liant le nucleotide guanine
|
|
EP1313854A2
(fr)
*
|
2000-07-07 |
2003-05-28 |
Incyte Genomics, Inc. |
Transporteurs et canneaux d'ion
|
|
US20030171324A1
(en)
*
|
2000-07-18 |
2003-09-11 |
Shyam Ramakrishnan |
Regulation of human desc1-like serine protease
|
|
WO2002006318A2
(fr)
*
|
2000-07-18 |
2002-01-24 |
Board Of Regents, The University Of Texas System |
Procedes et compositions permettant de stabiliser des microtubules et des filaments intermediaires dans des cellules de muscle strie
|
|
CA2416456A1
(fr)
*
|
2000-07-20 |
2002-01-31 |
Genentech, Inc. |
Polypeptides secretes et transmembranaires et acides nucleiques codant ces polypeptides
|
|
EP1303611A2
(fr)
*
|
2000-07-25 |
2003-04-23 |
MERCK PATENT GmbH |
Nouvelle proteine contenant le domaine doigt anneau r1p4
|
|
AU2001277202A1
(en)
*
|
2000-07-26 |
2002-02-05 |
Applied Genomics, Inc. |
Bstp-ras/rerg protein and related reagents and methods of use thereof
|
|
WO2002008281A2
(fr)
*
|
2000-07-26 |
2002-01-31 |
Stanford University |
Proteine bstp-cad et reactifs associes et methodes d'utilisation
|
|
EP1657254A3
(fr)
*
|
2000-08-01 |
2006-06-07 |
Genentech, Inc. |
Polypeptide, acides nucléiques le codant, et leur utilisation pour le diagnostic du cancer
|
|
US7335732B2
(en)
|
2000-08-01 |
2008-02-26 |
Genentech, Inc. |
PRO9799 polypeptides
|
|
EP1307557A2
(fr)
|
2000-08-02 |
2003-05-07 |
The Johns Hopkins University |
Profils d'expression de cellules endotheliales
|
|
WO2003024276A1
(fr)
*
|
2000-08-02 |
2003-03-27 |
Millennium Pharmaceuticals,Inc. |
Membre de la famille du facteur de liberation du gtp humain (15368) et ses utilisations
|
|
AU2001288231A1
(en)
*
|
2000-08-04 |
2002-02-18 |
Zymogenetics Inc. |
Human secreted protein, zzp1
|
|
WO2002012285A2
(fr)
|
2000-08-10 |
2002-02-14 |
Board Of Regents, The University Of Texas System |
Suppresseur de tumeur car-1
|
|
JP2004506422A
(ja)
*
|
2000-08-11 |
2004-03-04 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング |
新規マイトジェン活性化キナーゼ
|
|
EP1326985A1
(fr)
*
|
2000-08-18 |
2003-07-16 |
MERCK PATENT GmbH |
Identification d'un gene d'acetyltransferase n-terminale humaine
|
|
WO2002016587A2
(fr)
*
|
2000-08-21 |
2002-02-28 |
Incyte Genomics, Inc. |
Proteines associees aux microtubules et tubulines
|
|
US6706513B2
(en)
|
2000-08-21 |
2004-03-16 |
Bristol-Myers Squibb Company |
Adenosine deaminase homolog
|
|
AU2001284655A1
(en)
*
|
2000-08-24 |
2002-03-04 |
Eli Lilly And Company |
Nucleic acids, vectors, host cells, polypeptides and uses thereof
|
|
EP1313850B1
(fr)
|
2000-08-28 |
2008-08-06 |
Agensys, Inc. |
Acide nucleique et proteine correspondante denommes 85p1b3 utilises dans le traitement et la detection de cancers
|
|
AU2001284176A1
(en)
*
|
2000-08-28 |
2002-03-13 |
Astrazeneca Ab |
Molecules involved in the regulation of insulin in resistance syndrome (irs)
|
|
AU2001286714A1
(en)
*
|
2000-08-30 |
2002-03-13 |
Millennium Pharmaceuticals, Inc. |
54370, a novel human sulfate transporter and uses therefor
|
|
US20020146800A1
(en)
*
|
2000-08-30 |
2002-10-10 |
Curtis Rory A.J. |
48921, a novel human GTP releasing factor and uses therefor
|
|
WO2002018552A2
(fr)
*
|
2000-08-30 |
2002-03-07 |
Bayer Aktiengesellschaft |
Regulation d'enzyme humaine de type aminotransferase
|
|
WO2002018567A2
(fr)
*
|
2000-08-30 |
2002-03-07 |
Bayer Aktiengesellschaft |
Regulation d'enzyme humaine de type aminotransferase
|
|
AU2001288600A1
(en)
*
|
2000-08-31 |
2002-03-13 |
Millennium Pharmaceuticals, Inc. |
62112, a novel human dehydrogenase and uses thereof
|
|
WO2002020754A2
(fr)
*
|
2000-09-05 |
2002-03-14 |
Incyte Genomics, Inc. |
Molecules utilisees a des fins diagnostiques et therapeutiques
|
|
JP2004508043A
(ja)
|
2000-09-05 |
2004-03-18 |
アムジェン インコーポレイテッド |
Ｔｎｆレセプター様分子およびその使用
|
|
US20020142464A1
(en)
*
|
2000-09-08 |
2002-10-03 |
Millennium Pharmaceuticals, Inc. |
38646, a novel guanine nucleotide exchange factor and uses therefor
|
|
US6372468B1
(en)
|
2000-09-14 |
2002-04-16 |
Pe Corporation (Ny) |
Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
|
|
US6391606B1
(en)
*
|
2000-09-14 |
2002-05-21 |
Pe Corporation |
Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
|
|
JP2004531203A
(ja)
*
|
2000-10-05 |
2004-10-14 |
キュラジェン コーポレイション |
ヒトタンパク質、これらをコードするポリヌクレオチド、ならびにこれらの利用方法
|
|
AU2002220613A1
(en)
*
|
2000-10-11 |
2002-04-22 |
Bayer Aktiengesellschaft |
Regulation of human cyclophilin-type peptidyl-prolyl cis-trans isomerase
|
|
EP1402010A2
(fr)
*
|
2000-10-11 |
2004-03-31 |
Millennium Pharmaceuticals, Inc. |
Nouvel element de la famille des phosphatases humaines a double specificite, appele 8843, et utilisation de ce dernier
|
|
WO2002031143A2
(fr)
*
|
2000-10-12 |
2002-04-18 |
The Texas A & M University System |
Sequences d'acides nucleiques codant des proteines cmg, proteines cmg et leurs procedes d'utilisation
|
|
MXPA03003151A
(es)
*
|
2000-10-13 |
2003-08-19 |
Eos Biotechnology Inc |
Metodos de diagnostico de cancer de prostata, composiciones y metodos para seleccionar moduladores de cancer de prostata.
|
|
US6531297B2
(en)
*
|
2000-10-20 |
2003-03-11 |
Applera Corporation |
Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
|
|
EP1385861A2
(fr)
|
2000-10-25 |
2004-02-04 |
Diadexus, Inc. |
Compositions et techniques relatives a des genes et a des proteines specifiques du poumon
|
|
AU2002220668A1
(en)
*
|
2000-10-31 |
2002-05-15 |
Bayer Aktiengesellschaft |
Regulation of human glutathione-s-transferase
|
|
WO2002038743A2
(fr)
*
|
2000-11-09 |
2002-05-16 |
Glaxo Group Limited |
Enzyme
|
|
WO2002040672A2
(fr)
|
2000-11-20 |
2002-05-23 |
Diadexus, Inc. |
Compositions et methodes relatives a des genes et des proteines specifiques aux seins
|
|
AU2001297765A1
(en)
*
|
2000-12-05 |
2002-10-21 |
Incyte Genomics, Inc. |
Ligases
|
|
EP1339845A2
(fr)
|
2000-12-07 |
2003-09-03 |
ZymoGenetics, Inc. |
Proteine associee au complement adipocyte zacrp3x2
|
|
WO2002046477A2
(fr)
|
2000-12-07 |
2002-06-13 |
Chiron Corporation |
Retrovirus endogenes regules positivement dans le cancer de la prostate
|
|
WO2002048328A2
(fr)
*
|
2000-12-14 |
2002-06-20 |
Pe Corporation (Ny) |
Proteines kinases humaines isolees, molecules d'acide nucleique codant des proteines kinases humaines et utilisations associees
|
|
US20020142376A1
(en)
*
|
2000-12-20 |
2002-10-03 |
Gennady Merkulov |
Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
|
|
EP1409673B1
(fr)
|
2000-12-22 |
2006-06-07 |
Brystol-Myers Squibb Company |
Proteine humaine contenant une sequence repetee riche en leucine exprimee principalement dans l'intestin grele, hlrrsi1
|
|
US7892730B2
(en)
*
|
2000-12-22 |
2011-02-22 |
Sagres Discovery, Inc. |
Compositions and methods for cancer
|
|
US6423521B1
(en)
*
|
2000-12-28 |
2002-07-23 |
Pe Corporation (Ny) |
Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
|
|
WO2002053591A1
(fr)
*
|
2000-12-30 |
2002-07-11 |
Lion Bioscience Ag |
Cofacteur de recepteur nucleaire mammalien cf12 et ses procedes d'utilisation
|
|
US20030219739A1
(en)
*
|
2001-01-30 |
2003-11-27 |
Glass David J. |
Novel nucleic acid and polypeptide molecules
|
|
WO2002098917A2
(fr)
*
|
2001-02-12 |
2002-12-12 |
Curagen Corporation |
Proteines, polynucleotides codant pour lesdites proteines et methodes d'utilisation desdites proteines
|
|
EP1637601A3
(fr)
*
|
2001-02-21 |
2006-03-29 |
Curagen Corporation |
Protéines , polynucléotides codant pour ces protéines et procédés d'utilisation
|
|
US7271240B2
(en)
|
2001-03-14 |
2007-09-18 |
Agensys, Inc. |
125P5C8: a tissue specific protein highly expressed in various cancers
|
|
WO2002074906A2
(fr)
*
|
2001-03-16 |
2002-09-26 |
Eli Lilly And Company |
Proteines de mammiferes lp et reactifs associes
|
|
US6913904B2
(en)
*
|
2001-03-27 |
2005-07-05 |
Applera Corporation |
Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof
|
|
IL158293A0
(en)
|
2001-04-10 |
2004-05-12 |
Agensys Inc |
Nucleic acid and corresponding protein entitled 158p3d2 and pharmaceutical compositions containing the same
|
|
CA2443147A1
(fr)
|
2001-04-10 |
2002-10-24 |
Agensys, Inc. |
Acide nucleique et proteine correspondante intitulee 184p1e2, utilises dans le traitement et la detection de cancers
|
|
EP2280030A3
(fr)
|
2001-04-10 |
2011-06-15 |
Agensys, Inc. |
Acides nucléiques et protéines correspondantes utiles dans la détection et le traitement des différents cancers
|
|
CA2483507A1
(fr)
*
|
2001-04-24 |
2002-10-31 |
Isis Innovation Limited |
Enzyme et marqueur snp pour le depistage d'une maladie
|
|
CA2445309A1
(fr)
*
|
2001-04-24 |
2002-11-07 |
Otsuka Pharmaceutical Co., Ltd. |
Peptide de liaison a des anticorps de la maladie de crohn et methode d'examen de ladite maladie
|
|
WO2002090546A1
(fr)
*
|
2001-05-07 |
2002-11-14 |
Shionogi & Co., Ltd. |
Polypeptide servant de marqueur angiogenique et son adn
|
|
WO2002090543A2
(fr)
*
|
2001-05-09 |
2002-11-14 |
Bayer Aktiengesellschaft |
Régulation de la protéine semblable à celle de type 2c de la phosphatase de l'acide phosphatidique humain
|
|
US7157558B2
(en)
|
2001-06-01 |
2007-01-02 |
Genentech, Inc. |
Polypeptide encoded by a polynucleotide overexpresses in tumors
|
|
US7235358B2
(en)
*
|
2001-06-08 |
2007-06-26 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
|
US6905827B2
(en)
|
2001-06-08 |
2005-06-14 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
|
|
WO2003000901A2
(fr)
*
|
2001-06-26 |
2003-01-03 |
Decode Genetics Ehf. |
Acides nucleiques codant des proteines kinases
|
|
GB2399087A
(en)
*
|
2001-08-02 |
2004-09-08 |
Aeomica Inc |
Human zinc finger containing gene MDZ7
|
|
EP1423415A4
(fr)
*
|
2001-08-17 |
2005-04-06 |
Incyte Genomics Inc |
Molecules de signalisation intercellulaire
|
|
US7270960B2
(en)
|
2001-08-29 |
2007-09-18 |
Pacific Northwest Research Institute |
Diagnosis of ovarian carcinomas
|
|
WO2003023063A1
(fr)
*
|
2001-09-07 |
2003-03-20 |
Sankyo Company, Limited |
Methode d'estimation du risque d'apparition de diabetes
|
|
WO2003099318A2
(fr)
|
2002-05-29 |
2003-12-04 |
DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung |
Proteines specifiques du pancreas
|
|
WO2003040369A2
(fr)
*
|
2001-09-17 |
2003-05-15 |
Molecular Engines Laboratories |
Sequences impliquees dans les phenomenes de suppression tumorale, reversion tumorale, apoptose et/ou resistance aux virus et leur utilisation comme medicaments
|
|
WO2003025175A2
(fr)
*
|
2001-09-17 |
2003-03-27 |
Molecular Engines Laboratories |
Sequences impliquees dans les phenomenes de suppression tumorale, reversion tumorale, apoptose et/ou resistance aux virus et leur utilisation comme medicaments
|
|
WO2003029411A2
(fr)
|
2001-09-28 |
2003-04-10 |
Brigham Young University |
Nouveaux variants de la cyclooxygenase et methodes d'utilisation
|
|
EP1439225A4
(fr)
|
2001-10-04 |
2005-10-26 |
Kansai Tech Licensing Org Co |
Promoteur du gene dr5 et promoteur du gene siah-1
|
|
US7084257B2
(en)
|
2001-10-05 |
2006-08-01 |
Amgen Inc. |
Fully human antibody Fab fragments with human interferon-gamma neutralizing activity
|
|
WO2003031607A1
(fr)
*
|
2001-10-10 |
2003-04-17 |
Bayer Healthcare Ag |
Regulation de deshydrogenase/reductase des chaines courtes humaine
|
|
ATE364690T1
(de)
|
2001-11-09 |
2007-07-15 |
Proteologics Inc |
Posh nukleinsäure, polypeptide und darauf bezogene verfahren
|
|
AU2002365162A1
(en)
|
2001-11-14 |
2003-07-09 |
Northwestern University |
Self-assembly and mineralization of peptide-amphiphile nanofibers
|
|
JPWO2003044197A1
(ja)
*
|
2001-11-21 |
2005-03-24 |
独立行政法人科学技術振興機構 |
ハンチントン病遺伝子転写因子
|
|
US7151162B2
(en)
|
2001-12-06 |
2006-12-19 |
The University Of Children's Hospital Of Both Cantons Of Basel |
Nuclear protein
|
|
WO2003051911A2
(fr)
*
|
2001-12-19 |
2003-06-26 |
Genset S.A. |
Polypeptides et polynucleotides gmg-5 et utilisations de ceux-ci
|
|
JP2003245084A
(ja)
*
|
2001-12-20 |
2003-09-02 |
Morinaga Milk Ind Co Ltd |
脳梁又は精子の形成不全の診断及び治療に有用な新規遺伝子、並びにその用途
|
|
DE10163467A1
(de)
*
|
2001-12-21 |
2003-11-27 |
Axaron Bioscience Ag |
Protein 24B2 und zugrundliegende DNA-Sequenz
|
|
US6759222B2
(en)
|
2002-01-02 |
2004-07-06 |
Millennium Pharmaceuticals, Inc. |
14815, a human kinase family member and uses therefor
|
|
AU2003202543A1
(en)
*
|
2002-01-07 |
2003-07-24 |
Bayer Aktiengesellschaft |
Human phosphatidic acid phosphatase type 2-like protein
|
|
WO2003060109A2
(fr)
*
|
2002-01-15 |
2003-07-24 |
Bayer Healthcare Ag |
Regulation d'une subtilase humaine
|
|
AU2003205611A1
(en)
*
|
2002-01-15 |
2003-07-30 |
Medigene Ag |
Dilated cardiomyopathy associated gene-2 (dcmag-2): a cytoplasmatic inducer of sarcomeric remodeling in cardiomyocytes
|
|
JPWO2003062429A1
(ja)
*
|
2002-01-23 |
2005-05-26 |
山之内製薬株式会社 |
新規セリンプロテアーゼ
|
|
US7371719B2
(en)
|
2002-02-15 |
2008-05-13 |
Northwestern University |
Self-assembly of peptide-amphiphile nanofibers under physiological conditions
|
|
EP1338609A1
(fr)
*
|
2002-02-21 |
2003-08-27 |
MEMOREC Stoffel GmbH-Medizinisch-Molekulare Entwicklung, Köln |
Un outre récepteur KDR et son utilisation
|
|
AU2003225666A1
(en)
*
|
2002-03-05 |
2003-09-22 |
Applera Corporation |
Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
|
|
GB2388113A
(en)
*
|
2002-03-06 |
2003-11-05 |
Oxford Glycosciences |
B-cell malignancy-associated protein
|
|
EP3115470B1
(fr)
|
2002-03-13 |
2018-07-18 |
Genomic Health, Inc. |
Profilage de l'expression génétique dans des tissus de tumeurs prélevées par biopsie
|
|
AU2003220913A1
(en)
*
|
2002-03-19 |
2003-09-29 |
Tanabe Seiyaku Co., Ltd. |
Novel g protein-coupled recepotrs and genes thereof
|
|
US7527935B2
(en)
|
2002-03-19 |
2009-05-05 |
Mitsubishi Tanabe Pharma Corporation |
G-protein coupled receptor having eicosanoid as ligand and gene thereof
|
|
GB0206684D0
(en)
*
|
2002-03-21 |
2002-05-01 |
Babraham Inst |
Novel proteins
|
|
US7193069B2
(en)
|
2002-03-22 |
2007-03-20 |
Research Association For Biotechnology |
Full-length cDNA
|
|
CA2413475C
(fr)
|
2002-04-25 |
2010-07-27 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Expression de zap-70 en tant que marqueur de la leucemie chronique lymphoide/du lymphome a petits lymphocytes (lcl/lpl)
|
|
JP2004041003A
(ja)
*
|
2002-05-17 |
2004-02-12 |
Takeda Chem Ind Ltd |
新規タンパク質、そのｄｎａおよびその用途
|
|
WO2003101401A2
(fr)
|
2002-06-03 |
2003-12-11 |
Chiron Corporation |
Utilisation de nrg4, ou d'inhibiteurs de nrg4, dans le traitement du cancer du colon et du pancreas
|
|
EP1513934B1
(fr)
*
|
2002-06-06 |
2011-03-02 |
Oncotherapy Science, Inc. |
Genes et polypeptides en rapport avec les cancers du colon chez l'homme
|
|
EP1532161B1
(fr)
|
2002-06-13 |
2012-02-15 |
Novartis Vaccines and Diagnostics, Inc. |
Vecteurs pour l'expression de polypeptides hml-2
|
|
WO2004009626A1
(fr)
*
|
2002-07-22 |
2004-01-29 |
Yamanouchi Pharmaceutical Co., Ltd. |
Nouveau gene associe a l'arthrite rhumatoide
|
|
AU2003256074B2
(en)
|
2002-08-14 |
2011-02-03 |
National Institute Of Advanced Industrial Science And Technology |
Novel N-acetylgalactosamine transferases and nucleic acids encoding the same
|
|
AU2003243151A1
(en)
|
2002-08-16 |
2004-03-03 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
|
|
AU2003235316A1
(en)
*
|
2002-08-23 |
2004-03-11 |
Japan Science And Technology Agency |
Human solid cancer antigen peptides, polynucleotides encoding the same and utilization thereof
|
|
WO2004020662A2
(fr)
*
|
2002-08-27 |
2004-03-11 |
Epigenomics Ag |
Procede et acides nucleiques servant a l'analyse de troubles lies a la proliferation des cellules mammaires
|
|
US7452969B2
(en)
|
2002-08-30 |
2008-11-18 |
Licentia Ltd |
Neurotrophic factor protein and uses thereof
|
|
CN1703524B
(zh)
|
2002-09-30 |
2010-04-07 |
肿瘤疗法科学股份有限公司 |
与人胰腺癌相关的基因和多肽
|
|
AU2003294696A1
(en)
*
|
2002-10-17 |
2004-05-04 |
Evotec Neurosciences Gmbh |
Diagnostic and therapeutic use of the nicotinamide mononucleotide adenylytransferase 2 (nmnat-2) gene and protein for neurodegenerative diseases
|
|
AU2002952216A0
(en)
*
|
2002-10-23 |
2002-11-07 |
The Walter And Eliza Hall Institute Of Medical Research |
Novel therapeutic molecules
|
|
US7554021B2
(en)
|
2002-11-12 |
2009-06-30 |
Northwestern University |
Composition and method for self-assembly and mineralization of peptide amphiphiles
|
|
JP4606879B2
(ja)
|
2002-11-15 |
2011-01-05 |
ジェノミック ヘルス， インコーポレイテッド |
Ｅｇｆｒ陽性癌の遺伝子発現プロファイリング
|
|
DE10254601A1
(de)
|
2002-11-22 |
2004-06-03 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
|
AU2002953341A0
(en)
*
|
2002-12-13 |
2003-01-09 |
The Walter And Eliza Hall Institute Of Medical Research |
A novel phosphoprotein
|
|
AU2003287764B2
(en)
*
|
2002-12-13 |
2010-01-21 |
The Walter And Eliza Hall Institute Of Medical Research |
A novel phosphoprotein
|
|
US20040231909A1
(en)
|
2003-01-15 |
2004-11-25 |
Tai-Yang Luh |
Motorized vehicle having forward and backward differential structure
|
|
US7326768B2
(en)
|
2003-02-05 |
2008-02-05 |
Juan Saus |
Goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders
|
|
EP1445614A1
(fr)
*
|
2003-02-06 |
2004-08-11 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Méthodes d'évaluation in vitro de l'état de progression d'un virus HIV chez un individu
|
|
US7074891B2
(en)
|
2003-02-07 |
2006-07-11 |
Posco |
Leukocyte stimulating peptides
|
|
JP4568716B2
(ja)
|
2003-02-20 |
2010-10-27 |
ジェノミック ヘルス， インコーポレイテッド |
遺伝子発現を測定するためのイントロンｒｎａの使用
|
|
US20060142222A1
(en)
*
|
2003-03-04 |
2006-06-29 |
Makoto Ogino |
Novel gene relating to fibrotic conditions
|
|
RS54160B1
(sr)
*
|
2003-03-19 |
2015-12-31 |
Biogen Idec Ma Inc. |
Protein koji se vezuje za nogo receptor
|
|
ITRM20030149A1
(it)
|
2003-04-02 |
2004-10-03 |
Giuliani Spa |
Oligonucleotidi (odn) antisenso per smad7 e loro usi in campo medico
|
|
EP3470535B1
(fr)
|
2003-06-24 |
2020-04-01 |
Genomic Health, Inc. |
Prédiction de probabilité de récurrence de cancer
|
|
WO2005008213A2
(fr)
|
2003-07-10 |
2005-01-27 |
Genomic Health, Inc. |
Algorithme de profile d'expression et test du pronostic du cancer
|
|
EP2311468B1
(fr)
|
2003-08-08 |
2014-01-15 |
Perseus Proteomics Inc. |
Gène surexprimé dans le cancer
|
|
US20050136434A1
(en)
*
|
2003-08-12 |
2005-06-23 |
Mai Xu |
Isolated heat-inducible cell surface protein and hyperthermia-based tumor immunotargeting therapy
|
|
US20070178458A1
(en)
*
|
2003-09-05 |
2007-08-02 |
O'brien Philippa |
Methods of diagnosis and prognosis of ovarian cancer II
|
|
TW200517503A
(en)
*
|
2003-09-10 |
2005-06-01 |
Japan Science & Tech Agency |
Group of genes differentially expressed in peripheral blood cells and diagnostic method and assay method using the same
|
|
ES2346314T3
(es)
*
|
2003-10-02 |
2010-10-14 |
Glaxosmithkline Biolog Sa |
Antigenos de b. pertussis y uso de los mismos en vacunacion.
|
|
EP1685159B1
(fr)
|
2003-10-03 |
2012-08-01 |
Brigham & Women's Hospital |
Polypeptides de Tim-3
|
|
WO2005040791A2
(fr)
*
|
2003-10-21 |
2005-05-06 |
Bayer Healthcare Ag |
Diagnostics et therapeutiques pour maladies liees au recepteur de peptides similaire a la somatostatine et a l'angiogenine (salpr)
|
|
WO2005051994A2
(fr)
*
|
2003-11-21 |
2005-06-09 |
Zymogenetics, Inc. |
Facteur de necrose tumorale ztnf11
|
|
MXPA06006388A
(es)
*
|
2003-12-05 |
2006-09-04 |
Univ Northwestern |
Peptidos anfifilicos de auto-ensamble y metodos relacionados para el suministro del factor de crecimiento.
|
|
WO2005064019A2
(fr)
|
2003-12-23 |
2005-07-14 |
Genomic Health, Inc. |
Amplification universelle d'arn fragmente
|
|
US20050186577A1
(en)
|
2004-02-20 |
2005-08-25 |
Yixin Wang |
Breast cancer prognostics
|
|
ES2743125T3
(es)
*
|
2004-03-02 |
2020-02-18 |
Univ Johns Hopkins |
Mutaciones del gen de PIK3CA en cánceres humanos
|
|
TW200539890A
(en)
|
2004-03-12 |
2005-12-16 |
Brigham & Womens Hospital |
Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function
|
|
WO2005090569A1
(fr)
*
|
2004-03-24 |
2005-09-29 |
The Council Of The Queensland Institute Of Medical Research |
Cancer et acides nucleiques et proteines de testicule vsm1 et vsm2, et leurs utilisations
|
|
DE602005014354D1
(de)
*
|
2004-03-30 |
2009-06-18 |
Nsgene As |
Therapeutische verwendung des wachstumsfaktors nsg33
|
|
ES2550614T3
(es)
|
2004-04-09 |
2015-11-11 |
Genomic Health, Inc. |
Marcadores de expresión génica para predecir la respuesta a la quimioterapia
|
|
DE102004024617A1
(de)
|
2004-05-18 |
2005-12-29 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
|
WO2005118832A2
(fr)
*
|
2004-06-01 |
2005-12-15 |
Bayer Healthcare Ag |
Agents diagnostiques et therapeutiques pour des maladies associees a une proteine de type kinase regulee par serum/glucocorticoide (sgkl)
|
|
CA2572193A1
(fr)
|
2004-06-24 |
2006-01-05 |
Biogen Idec Ma Inc. |
Traitement d'etats pathologiques impliquant des oligodendrocytes avec des agents sp35
|
|
US7587279B2
(en)
|
2004-07-06 |
2009-09-08 |
Genomic Health |
Method for quantitative PCR data analysis system (QDAS)
|
|
CN101031581A
(zh)
*
|
2004-08-05 |
2007-09-05 |
东亚合成株式会社 |
克隆氏病抗体表位肽和检测克隆氏病的试剂
|
|
WO2006052731A2
(fr)
|
2004-11-05 |
2006-05-18 |
Genomic Health, Inc. |
Indicateurs moleculaires de pronostic de cancer du sein et prediction de reponse de traitement
|
|
CA3061785A1
(fr)
|
2004-11-05 |
2006-05-18 |
Genomic Health, Inc. |
Prediction de reaction a la chimiotherapie au moyen de marqueurs d'expression genique
|
|
US8367805B2
(en)
|
2004-11-12 |
2013-02-05 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
|
DK1817340T3
(da)
|
2004-11-12 |
2012-08-13 |
Xencor Inc |
Fc-varianter med ændret binding til fcrn
|
|
WO2006096614A2
(fr)
|
2005-03-04 |
2006-09-14 |
Northwestern University |
Epitopes angiogeniques de liaison a l'heparine, amphiphiles peptidiques, compositions auto-assemblees et procedes d'utilisation associes
|
|
WO2006120019A2
(fr)
*
|
2005-05-13 |
2006-11-16 |
Centre National De La Recherche Scientifique |
Utilisation de nouveau codage genique pour nouvel element de la famille mcm2-8 dans les compositions pharmaceutiques
|
|
EP2238986A3
(fr)
|
2005-07-08 |
2010-11-03 |
Biogen Idec MA Inc. |
Anticorps Sp35 et utilisations associées
|
|
WO2007014338A2
(fr)
*
|
2005-07-26 |
2007-02-01 |
Siemens Medical Solutions Diagnostics |
Polymorphismes de nucleotides uniques a susceptibilite par rapport a une maladie cardio-vasculaire
|
|
WO2007037601A1
(fr)
*
|
2005-09-28 |
2007-04-05 |
Knu-Industry Cooperation Foundation |
Polypeptide inhibant la transmigration de leucocytes ou la croissance et/ou la métastase de cellules cancéreuses, et une protéine de fusion de celui-ci
|
|
EP1790664A1
(fr)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Anticorps monoclonaux contre claudin-18 pour le traitement du cancer
|
|
CA2633468C
(fr)
|
2005-12-14 |
2014-02-18 |
Licentia Ltd |
Nouveau facteur neurotrophique et utilisations de celui-ci
|
|
AU2007271232A1
(en)
*
|
2006-07-03 |
2008-01-10 |
Exonhit Therapeutics Sa |
Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics
|
|
US20080108070A1
(en)
*
|
2006-09-08 |
2008-05-08 |
Corixa Corporation |
Methods, compositions, and kits for the detection and monitoring of colon cancer
|
|
US8076295B2
(en)
|
2007-04-17 |
2011-12-13 |
Nanotope, Inc. |
Peptide amphiphiles having improved solubility and methods of using same
|
|
US8999634B2
(en)
*
|
2007-04-27 |
2015-04-07 |
Quest Diagnostics Investments Incorporated |
Nucleic acid detection combining amplification with fragmentation
|
|
GB0805159D0
(en)
*
|
2008-03-19 |
2008-04-23 |
Sancho Madrid David |
Immune modulation via C-type lectin
|
|
NZ582822A
(en)
|
2007-07-27 |
2012-06-29 |
Immatics Biotechnologies Gmbh |
Novel immunogenic epitopes for immunotherapy
|
|
US7863021B2
(en)
|
2007-09-05 |
2011-01-04 |
Celera Corporation |
Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof
|
|
WO2009034661A1
(fr)
*
|
2007-09-12 |
2009-03-19 |
Toppan Printing Co., Ltd. |
Procédé de diagnostic et induction d'une résistance à un virus
|
|
WO2009050309A1
(fr)
|
2007-10-17 |
2009-04-23 |
Universidad De Cordoba |
Isoformes du récepteur de la somatostatine humaine de type 5 produites par traitement alternatif et paires d'oligonucléotides permettant de les détecter par pcr
|
|
ES2532461T3
(es)
|
2007-12-26 |
2015-03-27 |
Xencor, Inc. |
Variantes de FC con enlazamiento alterado a FCRN
|
|
GB0803352D0
(en)
|
2008-02-22 |
2008-04-02 |
Ntnu Technology Transfer As |
Oligopeptidic compounds and uses thereof
|
|
ES2584438T3
(es)
*
|
2008-03-21 |
2016-09-27 |
Universiteit Hasselt |
Biomarcadores para artritis reumatoide
|
|
AU2009269099B2
(en)
|
2008-07-09 |
2016-03-10 |
Biogen Ma Inc. |
Compositions comprising antibodies to LINGO or fragments thereof
|
|
EP2195013B1
(fr)
|
2008-07-24 |
2011-11-02 |
NsGene A/S |
Utilisation thérapeutique d'un facteur de croissance, metrnl
|
|
ES2536465T3
(es)
|
2008-10-01 |
2015-05-25 |
Immatics Biotechnologies Gmbh |
Composición de péptidos tumor-asociados y relacionados con la vacuna contra el cáncer para el tratamiento de glioblastoma (GBM) y otros cánceres
|
|
US9175353B2
(en)
|
2008-11-14 |
2015-11-03 |
Gen-Probe Incorporated |
Compositions, kits and methods for detection of campylobacter nucleic acid
|
|
WO2010062960A2
(fr)
|
2008-11-26 |
2010-06-03 |
Cedars-Sinai Medical Center |
Méthodes de détermination d'une réceptivité à une thérapie par anti-tnfα lors d’une maladie intestinale inflammatoire
|
|
CA2745849A1
(fr)
*
|
2008-12-09 |
2010-06-17 |
Alethia Biotherapeutics Inc. |
Nouveau variant retroviral endogene humain d'erv3 et utilisations de celui-ci pour diagnostiquer le cancer des ovaires
|
|
JP2012523463A
(ja)
|
2009-04-13 |
2012-10-04 |
ノースウエスタン ユニバーシティ |
軟骨再生のための新規なペプチドベースの足場およびその使用方法
|
|
US9493578B2
(en)
|
2009-09-02 |
2016-11-15 |
Xencor, Inc. |
Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens
|
|
JP6210685B2
(ja)
*
|
2010-01-27 |
2017-10-11 |
マサチューセッツ インスティテュート オブ テクノロジー |
標的化された広域スペクトルのインフルエンザ中和のための操作されたポリペプチド剤
|
|
LT2621526T
(lt)
|
2010-09-29 |
2018-09-25 |
Agensys, Inc. |
Antikūno-vaisto konjugatai (adc), kurie jungiasi prie 191p4d12 baltymų
|
|
EP2621512B1
(fr)
|
2010-10-01 |
2016-04-06 |
NsGene A/S |
Utilisation de la météorine pour le traitement de l'allodynie, de l'hyperalgésie, de la douleur spontanée et de la douleur illusionnelle
|
|
DK2651430T3
(en)
|
2010-12-14 |
2018-08-27 |
Hananja Ehf |
Biological activity of placental protein 13
|
|
JP6145667B2
(ja)
|
2011-09-05 |
2017-06-14 |
ホーバ セラピューティクス アンパルトセルスカブ |
アロディニア、痛覚過敏、自発痛、及び幻痛の治療
|
|
AR088699A1
(es)
*
|
2011-11-09 |
2014-06-25 |
Sanofi Sa |
Diacilglicerol lipasa y usos de la misma
|
|
EP3489254B9
(fr)
|
2012-04-30 |
2022-12-21 |
Biocon Limited |
Protéines de fusion ciblées/immunomodulatrices et leurs procédés de fabrication
|
|
WO2013167153A1
(fr)
|
2012-05-09 |
2013-11-14 |
Ganymed Pharmaceuticals Ag |
Anticorps utiles dans le diagnostic du cancer
|
|
JP2015518829A
(ja)
|
2012-05-14 |
2015-07-06 |
バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎ ＭＡ Ｉｎｃ． |
運動ニューロンに関する状態の処置のためのｌｉｎｇｏ−２アンタゴニスト
|
|
WO2013174404A1
(fr)
|
2012-05-23 |
2013-11-28 |
Ganymed Pharmaceuticals Ag |
Polythérapie impliquant des anticorps dirigés contre la claudine 18,2 pour le traitement du cancer
|
|
MX369276B
(es)
|
2012-11-13 |
2019-11-04 |
Biontech Ag |
Agentes para tratamiento de enfermedades cancerosas que expresan claudina.
|
|
WO2014127785A1
(fr)
|
2013-02-20 |
2014-08-28 |
Ganymed Pharmaceuticals Ag |
Polythérapie impliquant des anticorps dirigés contre la claudine 18,2 pour le traitement du cancer
|
|
US9023353B2
(en)
*
|
2013-03-13 |
2015-05-05 |
The Board Of Trustees Of The University Of Arkansas |
Anti-(+)—methamphetamine monoclonal antibodies
|
|
WO2014146672A1
(fr)
|
2013-03-18 |
2014-09-25 |
Ganymed Pharmaceuticals Ag |
Thérapie comprenant des anticorps dirigés contre cldn 18.2 pour le traitement du cancer
|
|
CN105246501B
(zh)
|
2013-03-27 |
2021-01-12 |
雪松-西奈医学中心 |
通过抑制tl1a的功能和相关信号传导途径来减轻并逆转纤维化和炎症
|
|
HRP20211563T1
(hr)
|
2013-07-11 |
2022-01-07 |
Modernatx, Inc. |
Pripravci koji sadrže sintetske polinukleotide koji kodiraju proteine srodne crispr-u i sintetske sgrna, te postupci njihove uporabe
|
|
EP3022295A4
(fr)
|
2013-07-19 |
2017-03-01 |
Cedars-Sinai Medical Center |
Signature de la voie de signalisation de tl1a (tnfsf15)
|
|
AU2014324884B2
(en)
|
2013-09-25 |
2020-03-26 |
Cytomx Therapeutics, Inc |
Matrix metalloproteinase substrates and other cleavable moieties and methods of use thereof
|
|
CA2925658C
(fr)
*
|
2013-10-01 |
2022-12-06 |
Mie University |
Antigene contenant une sequence d'interepitope favorisant la presentation d'antigene aux cellules t
|
|
WO2015116933A2
(fr)
|
2014-01-31 |
2015-08-06 |
Cytomx Therapeutics, Inc. |
Substrats pour matriptase et activateur u-plasminogène et autres fractions clivables, et leurs procédés d'utilisation
|
|
CA2973266A1
(fr)
|
2015-01-08 |
2016-07-14 |
Biogen Ma Inc. |
Antagonistes de lingo-1 et leurs utilisations pour le traitement de troubles de demyelinisation
|
|
MA41374A
(fr)
|
2015-01-20 |
2017-11-28 |
Cytomx Therapeutics Inc |
Substrats clivables par métalloprotéase matricielle et clivables par sérine protéase et procédés d'utilisation de ceux-ci
|
|
US11124766B2
(en)
*
|
2015-06-12 |
2021-09-21 |
Emory University |
Growth and survival compositions for cells capable of producing antibodies and methods related thereto
|
|
EP3344776B1
(fr)
*
|
2015-09-04 |
2021-06-16 |
Synthetic Genomics, Inc. |
Micro-organisme recombinant algal de productivité accrue
|
|
EP3430172A4
(fr)
|
2016-03-17 |
2019-08-21 |
Cedars-Sinai Medical Center |
Méthode de diagnostic d'une maladie inflammatoire chronique de l'intestin par l'intermédiaire de rnase t2
|
|
WO2017172941A2
(fr)
*
|
2016-03-29 |
2017-10-05 |
Berz David |
Modulation de l'entretien structural de l'expression du chromosome-1
|
|
US9611297B1
(en)
|
2016-08-26 |
2017-04-04 |
Thrasos Therapeutics Inc. |
Compositions and methods for the treatment of cast nephropathy and related conditions
|
|
US11125757B2
(en)
|
2017-05-26 |
2021-09-21 |
Emory University |
Methods of culturing and characterizing antibody secreting cells
|
|
EP3508499A1
(fr)
|
2018-01-08 |
2019-07-10 |
iOmx Therapeutics AG |
Anticorps ciblant et d'autres modulateurs d'un gène d'immunoglobuline associé à une résistance contre des réponses immunitaires antitumorales et leurs utilisations
|
|
CA3146023A1
(fr)
|
2019-07-05 |
2021-01-14 |
Iomx Therapeutics Ag |
Anticorps de liant a l'igc2 de l'igsf11 (vsig3) et leurs utilisations
|
|
WO2021083958A1
(fr)
*
|
2019-10-29 |
2021-05-06 |
Specialites Pet Food |
Nouveaux peptides induisant la satiété
|
|
EP4149952A1
(fr)
*
|
2020-05-12 |
2023-03-22 |
Institut Curie |
Épitopes néo-antigéniques associés à des mutations sf3b1
|
|
WO2022008027A1
(fr)
|
2020-07-06 |
2022-01-13 |
Iomx Therapeutics Ag |
Anticorps de liaison à l'igv d'igsf11 (vsig3) et leurs utilisations
|
|
JP2024504690A
(ja)
*
|
2021-01-21 |
2024-02-01 |
エラスムス・ユニヴァーシティ・メディカル・センター・ロッテルダム |
治療における使用のためのｔ細胞
|
|
JP2024509376A
(ja)
*
|
2021-02-18 |
2024-03-01 |
ベレン セラピューティクス ピー．ビー．シー． |
家族性ヘテロ接合型及びホモ接合型高コレステロール血症のシクロデキストリンによる治療方法
|
|
WO2023225602A1
(fr)
*
|
2022-05-20 |
2023-11-23 |
Medikine, Inc. |
Polypeptides de liaison au récepteur de l'interleukine-18 et leurs utilisations
|